CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...